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Introduction
Fetal to maternal hemorrhage (FMH), is fetal blood loss into the
maternal circulation, occurring before or during delivery. Fetal blood
transfer into the mother’s bloodstream may likely occur in all
pregnancies in small volumes due to placental leak during normal
pregnancy and delivery. Moderate to severe fetal to maternal
hemorrhage occurs in 0.3% of births, which are clinically significant,
causing profound neonatal anemia.1,2 No definition of severe FMH
has been accepted, with many different volumes being used.2 FMH
is responsible for causing an estimated 14% of fetal deaths.3
However, as FMH is not well understood, in part because diagnosis
is difficult and highly physician dependent, the incidence of severe
FMH incidence is likely underreported.2,4 FMH has a vague
presentation, with the most common symptom being decreased
fetal movement. Diagnosis is most frequently made using the
Kleihauer-Betke test which measures the amount of fetal
hemoglobin in the mother’s blood, however the test has multiple
drawbacks. The consequences of significant FMH are potentially life
threatening for the fetus or neonate, causing anemia or neurologic
injury, among other serious complications.

Case History
• Female infant born at 36 weeks gestation with birth weight of 2580 grams
• Mother was 31 years old; gravida 1
• Mother reported decreased fetal movement 3 days prior and a quartersized amount blood-tinged mucous vaginal discharge 2 days prior.
• Non-stress test was non-reactive, and cesarean section was performed.
• Spontaneous cry, extremely pale, and mild respiratory distress at birth
• CPAP and supplemental oxygen given to infant
• Apgar scores were 8 and 8 at 1 and 5 minutes.

An example of a positive Kleihauer-Betke test:
Fetal hemoglobin (HbF) in red blood cells is
resistant to acid elution. Red blood cells which
contain HbF will remain bright red, while those
without HbF will appear colorless.

Discussion
• FMH presentation is often nonspecific and without a precipitating factor.
Decreased fetal movement is the most common presentation, occurring in 25%
of cases. Abnormal fetal heart rate has been associated with FMH and fetal
anemia, however it is seen in less than 10%.1 The vague presentation of FMH
creates great difficulty in its diagnosis. The difficulty of prenatal diagnosis forces
providers to rely heavily on postnatal clues, such as pallor and anemia in the
neonate.
• When a non-stress test is non-reactive, a Kleihauer-Betke (KB) test should be
performed.5 This blood test measures the amount of fetal hemoglobin (HbF)
present in the mother’s bloodstream. The KB test is inexpensive and widely
used, however it is labor-intensive, lacks standardization and results depend on
the technician’s skills.6 It cannot be used if the mother has a condition with HbF
such as sickle-cell anemia, beta thalassemia trait or hereditary persistence of
HbF. An example of what a positive KB test looks like is shown in Figure 2.
• Flow cytometry can be used instead of KB test to diagnose FMH. Flow
cytometry is faster and less labor-intensive, which raises its precision and
accuracy, however it is not yet widely used. Neither test gives insight into when
the hemorrhage occurred.6
• The outcomes of FMH are variable. Small hemorrhages may be common, and
without any symptoms. However, larger hemorrhages can lead to severe fetal
anemia. If not identified or treated properly, fetal anemia can lead to neurologic
injury or death in the neonate. 2,4
• A high level of suspicion must be kept to detect signs of FMH and action taken
swiftly. If providers do not order FMH testing such as the KB or flow cytometry
in response to neonatal anemia soon after birth, the diagnosis of FMH may be
missed.

• CBC on admission showed profound neonatal anemia: Hb was 3.8 mg/dl;
HCT 11.7%, reticulocyte 25.6%; and bilirubin 1.3 mg/dl.
• Given emergency transfusion of 15 mL/kg packed RBCs. Color and
perfusion improved.
• Given second transfusion at 16 hours of age.
• Maternal Kleihauer-Betke test for HbF was 18% indicating a fetal to
maternal hemorrhage as the cause of fetal anemia.
• Infant had a normal brain MRI on day 5.

Conclusions
FMH is a severe phenomenon which is not well understood. It is difficult
to recognize, likely underreported, and the current diagnostic testing is
inadequate.
Due to its complexity and rarity, physicians and healthcare staff should
be educated to promote detection of the vague presenting signs of FMH.

• Infant discharged on day 8, feeding well.

Further research should be done to determine the true incidence of
significant FMH and better insight into clinical presentation.

Figure 1 Changes to hematocrit levels by age of newborn in hours
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